搜索历史清除全部记录
- All
- Product Management
- News and Information
- Introduction content
- Business outlets
- Frequently Asked Questions
- Corporate Video
- Corporate Portfolio
Strictly controlling quality and strengthening learning exchanges—Baihui Pharmaceutical Conducts On-site Audit and Inspection Activities for Raw Material and Excipient Suppliers
Release date:
2021-09-30
To further enhance the supervision of raw material quality and strengthen communication with suppliers of primary and auxiliary packaging materials, Baohui Pharmaceutical conducted on-site audit inspections of its raw and auxiliary material suppliers from September 27 to 29, 2021, in alignment with national GMP regulatory requirements.
During this audit and inspection activity, the team first conducted a detailed audit of Shandong Ahua Pharmaceutical Materials Technology Co., Ltd.'s raw materials and excipients, evaluating key indicators such as quality management, production processes, and the production environment. In addition, the Baihui Pharmaceutical audit team engaged in in-depth discussions with Shandong Ahua Pharmaceutical Materials Technology Co., Ltd. on various operational aspects, including production technology and on-site management.
The progress and development of enterprises require continuous learning and exchange. This specialized inspection activity not only helps Baiyao Pharmaceutical further enhance its quality management and supervision over raw material and excipient suppliers, but also enables Baihui Pharmaceutical to learn advanced management practices and philosophies from leading companies. By adhering to the principles of "high-quality raw materials, cutting-edge production technology, and a people-oriented approach," both companies are committed to pursuing a path of scientific and technological innovation, strengthening their ability to foster independent innovation, achieving strategic business growth, and ultimately building themselves into world-class, modern pharmaceutical enterprises.
Follow us